Arturo Loaiza-Bonilla

Co-Founder, Massive Bio | Chief Medical AI Officer (CMAIO) | Systemwide Chief of Hematology and Medical Oncology, St. Luke's University Health Network (SLUHN)

MD, MSEd, FACP · AI in Oncology; Precision Oncology; Hematology & Medical Oncology; Clinical Trial Design/Execution · Greater Philadelphia; Pennsylvania & New Jersey (SLUHN oncology)

Biography

Dr. Arturo Loaiza-Bonilla, MD, MSEd, FACP is a physician–scientist and oncology executive operating at the intersection of clinical medicine, artificial intelligence, and large-scale clinical research infrastructure.

Clinical interests / subspecialty

Biomarker-driven cancers; immunotherapy; complex trial-based care; clinical trial access/matching infrastructure; neurosymbolic & multi-agent AI platforms

Education & training

Medical School: University of Miami Miller School of Medicine

Residency: St. Luke's-Roosevelt Hospital Center, Columbia University, Internal Medicine

Fellowship: Post-Doctorate Fellow, Hematology and Oncology (University of Miami Miller School of Medicine)

Other training: Master of Medical Education (MSEd), Medical Education (University of Pennsylvania)

Board certifications / licenses

  • ABIM - Medical Oncology
  • ABIM - Internal Medicine

Professional memberships

ASCO, AACR, ACP (Fellow)

Languages

English (native); French (professional working proficiency); Japanese (elementary proficiency); Spanish (native or bilingual proficiency)

Research areas

AI in clinical trials; neurosymbolic / multi-agent AI architectures; digital health; real-world data activation; precision oncology systems

Clinical research experience

Phase I–III clinical trial leadership and portfolios across oncology networks

Leadership & recognition

  • 40 under 40 in Cancer; Philadelphia Business Journal “40 Under 40”; Castle Connolly / Philadelphia Magazine Top Doctors (since 2018)

Publications & media

  • 80+ peer-reviewed publications in NEJM AI, JCO, Lancet Oncology, ESMO and JAMA Oncology
  • PubMed

Arturo Loaiza-Bonilla reviews Massive Bio content as part of our Medical Review Board, ensuring medical accuracy and clinical currency across our cancer resources.

Content reviewed by Arturo Loaiza-Bonilla

Symptômes du cancer du poumon de stade 1 : quand consulter un médecin

MAY 2025

Témoignages Réels : Comment j’ai découvert que j’avais un cancer du poumon

MAY 2025

Décryptage des taux de survie du cancer du poumon selon l’âge et le stade

MAY 2025

Qu’est-ce que la myélofibrose

MAY 2025

Cancer du sein inflammatoire au stade précoce : à quoi cela ressemble-t-il

MAY 2025

Symptômes rares du cancer du poumon que vous ne devez pas ignorer

MAY 2025

Comprendre le pronostic du myélome multiple : quels sont les facteurs les plus importants?

APRIL 2025

Comment la localisation de la tumeur influence le traitement du cancer du poumon à petites cellules

APRIL 2025

Massive Bio reçoit son attestation de certification par la CNIL pour sa mise en conformité au RGPD !

APRIL 2025

Tumeur au Cerveau : Guide Simple pour Comprendre Votre Diagnostic

FEBRUARY 2025

Fibromes Utérins : Symptômes, Traitements et Options Médicales

FEBRUARY 2025

Métastases Osseuses: Symptômes et Options de Traitement

JANUARY 2025

Understanding Lung Adenocarcinoma: Symptoms and Treatments

JANUARY 2025

Adénocarcinome Pulmonaire : Symptômes, Traitements et Évolution

JANUARY 2025

Comment Prévenir le Cancer du Côlon : 5 Conseils Essentiels

DECEMBER 2024

J’ai guéri du cancer du pancréas

NOVEMBER 2024

Cancer Ovaire Symptome

OCTOBER 2024

Cancer Amygdale

OCTOBER 2024

Symptome Cancer Estomac

OCTOBER 2024

Albumine Cancer

OCTOBER 2024

Refusing Hormone Therapy For Breast Cancer : What To Know

SEPTEMBER 2024

Cancer Urothélial

SEPTEMBER 2024

Syndrome Myélodysplasique

SEPTEMBER 2024

Cancer De l’utérus Symptome Stade 1

SEPTEMBER 2024

No articles match your search.